U.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International

ATI

31/08/2026 08:24

Aug 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Braveheart Bio and CACI International, on Monday. 

HIGHLIGHTS
* Abercrombie & Fitch Co. ANF.N: Argus Research raises to buy from hold
* Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230
* Braveheart Bio, Inc. BRVE.O: Jefferies initiates coverage with buy rating
* CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550
* Edison International EIX.N: Mizuho cuts to neutral from outperform

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Abercrombie & Fitch Co. ANF.N: Argus Research raises to buy from hold
* Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230
* Affirm Holdings, Inc. AFRM.O: Bernstein raises target price to $110 from $100
* Airjoule Technologies Corporation AIRJ.O: Needham initiates coverage with hold rating
* Ascendis Pharma A/S ASND.O: H.C. Wainwright cuts target price to $344 from $345
* ATI Inc ATI.N: TD Cowen raises target price to $250 from $210
* Attovia Therapeutics ATTO.O: Leerink Partners initiates coverage with outperform rating
* Attovia Therapeutics ATTO.O: Leerink Partners initiates coverage with target price $52
* Autodesk, Inc. ADSK.O: Citigroup raises target price to $276 from $269
* Babcock & Wilcox Enterprises, Inc. BW.N: Needham initiates coverage with buy rating
* Babcock & Wilcox Enterprises, Inc. BW.N: Needham initiates coverage with PT $20
* Biomarin Pharmaceutical BMRN.O: H.C. Wainwright raises target price to $60 from $59
* Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with buy rating
* Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with target price $48
* Braveheart Bio, Inc. BRVE.O: Stifel initiates coverage with buy rating; target price $45
* Braveheart Bio, Inc. BRVE.O: TD Cowen initiates coverage with buy rating
* BRC Inc BRCC.N: D.A. Davidson adjusts target price to $25 from $2.5 to reflect 1-for-10 reverse stock split
* Burlington Stores, Inc. BURL.N: Deutsche Bank cuts target price to $323 from $367
* CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550
* Ciena Corporation CIEN.N: B. Riley cuts target price to $413 from $516
* Deere & Co DE.N: Raymond James raises target price to $730 from $700
* Dollar Tree Inc DLTR.O: Piper Sandler raises target price to $121 from $114
* Edison International EIX.N: Mizuho cuts target price to $70 from $86
* Edison International EIX.N: Mizuho cuts to neutral from outperform
* Entergy ETR.N: Jefferies cuts target price to $133 from $139
* Five9, Inc. FIVN.O: Truist Securities raises target price to $40 from $35
* Healthequity HQY.O: Deutsche Bank raises target price to $142 from $135
* Honeywell Aerospace Inc HONA.O: TD Cowen cuts target price to $180 from $250
* IBM IBM.N: Susquehanna raises target price to $235 from $225
* Intercontinental Exchange Inc ICE.N: Jefferies raises target price to $189 from $171
* Intuitive Machines Inc LUNR.O: BofA Global Research raises price objective to $13 from $11
* Kaiser Aluminum Corporation KALU.O: UBS raises target price to $184 from $179
* Kaiser Aluminum Corporation KALU.O: UBS raises to buy from neutral
* Mongodb, Inc. MDB.O: Monness Crespi Hardt raises target price to $460 from $415
* Omega Healthcare Investors, Inc. OHI.N: Mizuho raises target price to $46 from $45
* PayPal PYPL.O: Clear Street cuts target price to $55 from $61
* PayPal PYPL.O: Mizuho cuts target price to $51 from $60
* PayPal PYPL.O: Truist Securities cuts target price to $53 from $62
* PG&E Corp PCG.N: BMO cuts target price to $21 from $28
* PG&E Corp PCG.N: BMO cuts to market perform from outperform
* PG&E Corp PCG.N: Mizuho cuts to neutral from outperform; cuts PT to $16 from $21
* Popular, Inc BPOP.O: Benchmark raises target price to $216 from $214
* Protagonist Therapeutics Inc PTGX.O: Jefferies raises target price to $171 from $169
* Protagonist Therapeutics, Inc. PTGX.O: H.C. Wainwright raises target price to $170 from $167
* Redwire Corporation RDW.N: BofA Global Research raises price objective to $8 from $7
* Revolution Medicines, Inc. RVMD.O: Needham raises target price to $275 from $240
* River City Bank RCBC.O: Raymond James initiates coverage with outperform rating; PT $56
* Rocket Lab Corp RKLB.O: BofA Global Research cuts price objective to $110 from $115
* Rubrik Inc RBRK.N: CIBC raises target price to $120 from $115
* Rubrik, Inc. RBRK.N: Citigroup raises target price to $130 from $96
* Sabra Health Care Reit, Inc. SBRA.O: Mizuho raises target price to $21 from $20
* Salesforce, Inc. CRM.N: Argus Research raises target price to $300 from $290
* Scribe Therapeutics Inc. SCTX.O: H.C. Wainwright initiates coverage with target price $60
* Scribe Therapeutics Inc. SCTX.O: H.C. Wainwright initiates coverage with buy rating
* Sempra SRE.N: Mizuho cuts to neutral from outperform; cuts target price to $84 from $104
* Strive Inc ASST.O: TD Cowen raises target price to $32 from $28
* T. Rowe price Group, Inc. TROW.O: TD Cowen raises target price to $110 from $108
* Uipath Inc PATH.N: UBS raises target price to $19 from $12
* Voyager Technologies Inc (Prereincorporation) VOYG.N: BofA Global Research raises price objective to $45 from $39


 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))